ACM
AVNR

Atika Capital Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Atika Capital Management’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-128,674
Closed -$2.18M – 91
2014
Q4 		$2.18M Sell
128,674
-6,326
-5% -$89K 1.59% 22
2014
Q3 		$1.61M Buy
135,000
+80,000
+145% +$546K 1.24% 34
2014
Q2 		$310K Buy
+55,000
New +$253K 0.25% 59

Atika Capital Management's AVNR Position: Q1 2015 in Review

Atika Capital Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 128,674 shares — an estimated $2.18M sold.

Atika Capital Management first reported a position in AVNR in Q2 2014 and held it in 3 quarters. The position peaked at $2.18M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Atika Capital Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Atika Capital Management sold 128,674 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $2.18M.
  • Atika Capital Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2014 and held it in 3 quarters.
  • Atika Capital Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.18M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Atika Capital Management's 13F filing for Q1 2015, filed 15 May 2015.